QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT Solicitation ID/Procurement Identifier: 75N93021R00020 Ultimate Completion Date: Sun Apr 14 17:00:00 GMT 2030
Introduction: This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate...
The attached JOFOC authorizes an increase in the level of effort for the base requirement (Options 2-6) by 20 FTEs/year, from 62 FTEs/year to 82 FTEs/year, under contract No. HHSN272201700004C with PPD Development, LP.
Product Service Code:- A - RESEARCH AND DEVELOPMENTNAICS Code:- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Primary point of contact:- Kishan Patelpatelki@niaid.nih.govPhone Number 240-669-5157Secondary point of contact:- Michelle A Scalamscala@niaid.nih.govPhone Number 240-669-5156
The mission of the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH) is to ensure an end to the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic by supporting research that can lead to the development of therapies, vaccines, and prevention strategies. Since the mid-1980's animal models have played an important role in the Institute's efforts to achieve its mission.Nonhuman primate (NHP) models present the opportunity to test a variety of candidate AIDS vaccines, optimizing their ability to elicit immune responses and testing their ability to prevent infection or to control virus replication after virus challenge. NHP models can be us...
IntroductionNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) conducts and supports epidemiological and clinical research on infectious diseases. Many of the large clinical and epidemiological studies funded by NIAID collect biologic specimens from subjects for ongoing and future studies. The collection and storage of these specimens from many different research studies in a single repository is a valuable resource with which researchers can rapidly validate scientific hypotheses and algorithms for clinical decision-making. Comprehensive and well-maintained specimen collections coupled with epidemiologic data have facilitated research on the pathogenesis of HIV disease, development of nove...
Anticipated Period of PerformanceThe anticipated period of performance is March 1, 2021 through May 31, 2022, with four options to extend services for an additional 12 period per option, through August 14, 2024 (if all term options are exercised)Anticipated award date: March 01, 2021IntroductionThe National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), conducts and supports research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. The mission of Division of AIDS (DAIDS), NIAID, is to bring an end to the HIV/AIDS epidemic by increasing the basic knowledge of the pathogenesis and transmission of HIV, to support the advancement of therapies for HIV...
